BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines water Consumption — Manufacturing & R&D Sites (m³)
BeOne Responsible Business & Sustainability Report (ESG)
Latest, FY2025
1,109,255
Period ended Dec 31, 2025
Change on a year earlier
+47.8%
750,476 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Water Consumption — Manufacturing & R&D Sites (m³) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,109,255 | +47.8% | 2025 ESG Report ↗ |
| FY2024 | Dec 31, 2024 | 750,476 | +13.8% | 2025 ESG Report ↗ |
| FY2023 | Dec 31, 2023 | 659,463 | -2.1% | 2025 ESG Report ↗ |
| FY2022 | Dec 31, 2022 | 673,844 | +96.9% | 2024 ESG Report ↗ |
| FY2021 | Dec 31, 2021 | 342,172 | +15.6% | 2021 ESG Report ↗ |
| FY2020 | Dec 31, 2020 | 295,957 | +124.1% | 2021 ESG Report ↗ |
| FY2019 | Dec 31, 2019 | 132,074 | – | 2021 ESG Report ↗ |
Cite this data
StockData. (2026). BeOne Medicines Water Consumption — Manufacturing & R&D Sites (m³), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/esg_water_prod
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.